Hollmann K H, Verley J M
Experientia. 1980 Oct 15;36(10):1213-5. doi: 10.1007/BF01976136.
Female Sprague-Dawley rats bearing primarily-induced mammary carcinomas were treated with a new immunostimulating agent (P 40). The histopathological modifications encountered in tumors, lymph nodes, liver and spleen are described. Intratumoral injections provoke a more widespread response of the RES, and particularly a more intense reaction in the draining lymph nodes, than systemic treatment.
对原发性诱发乳腺癌的雌性斯普拉格-道利大鼠使用一种新型免疫刺激剂(P 40)进行治疗。描述了在肿瘤、淋巴结、肝脏和脾脏中遇到的组织病理学改变。与全身治疗相比,瘤内注射引起网状内皮系统更广泛的反应,尤其是引流淋巴结中更强烈的反应。